levonorgestrel has been researched along with HIV Coinfection in 67 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (2.99) | 18.2507 |
| 2000's | 7 (10.45) | 29.6817 |
| 2010's | 30 (44.78) | 24.3611 |
| 2020's | 28 (41.79) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishna, Y; d'Hellencourt, FC; Hofmeyr, GJ; Lawrie, TA; Singata-Madliki, M | 1 |
| Brand, RM; Cottrell, ML; Gatto, GJ; Johnson, LM; Krovi, SA; Li, L; Norton, C; van der Straten, A | 1 |
| Baeten, JM; Beesham, I; Beksinka, M; Bukusi, E; Deese, J; Donnell, D; Edward, V; Heffron, R; Kourtis, AP; Morrison, C; Mugo, NR; Philip, NM; Rees, H; Scoville, CW; Stalter, RM | 1 |
| Ankrom, W; Brimhall, D; Fillgrove, KL; Gravesande, KN; Iwamoto, MN; Jackson Rudd, D; Matthews, RP; Stoch, SA; Zhang, S | 1 |
| Baeten, JM; Bosinger, SE; Bunjun, R; Burgener, A; Dabee, S; Gamieldien, H; Happel, AU; Harryparsad, R; Heffron, R; Heller, K; Jaspan, HB; Jaumdally, SZ; Nair, G; Onono, M; Palanee-Phillips, T; Passmore, JAS; Qumbelo, Y; Scoville, CW; Sinkala, M; Tanko, RF | 1 |
| Ahmed, K; Bailey, V; Beksinska, M; Buck, G; Chen, PL; Deese, J; Gao, X; Harryparsad, R; Lefebvre d'Hellencourt, F; Masson, L; Mehou-Loko, C; Meyer, B; Morrison, C; Nanda, K; Radzey, N; Serrano, M; Smit, J; Strauss, J; Taku, O; Williamson, AL | 1 |
| Allen, SA; Dabee, S; Doncel, GF; Feng, C; Gasper, M; Haugen, HS; Heffron, R; Jaspan, HB; McLellan-Lemal, E; Mudhune, V; Mugo, N; Njoroge, B; Nyagol, B; O'Connor, S; Ouma, E; Peacock, S; Ridzon, R; Thurman, AR; Wiener, J | 1 |
| Ayele, H; Baeten, JM; Bosinger, SE; Brown, BP; Bunjun, R; Burgener, A; Dabee, S; Gamieldien, H; Harryparsad, R; Heffron, R; Heller, KB; Jaspan, H; Jaumdally, SZ; Nair, G; Noël-Romas, L; Onono, M; Palanee-Phillips, T; Passmore, JS; Ramla, TF; Scoville, CW | 1 |
| Byakika-Kibwika, P; Chappell, CA; Fletcher, CV; Jeppson, J; Kaboggoza, J; Kyohairwe, I; Lamorde, M; Mbabazi, L; Musaazi, J; Nakalema, S; Nakijoba, R; Nassiwa, S; Pham, M; Scarsi, KK; Siccardi, M; Walimbwa, SI; Winchester, L | 1 |
| Amorim, G; Bernard, C; Bukusi, EA; Cohen, CR; Jakait, B; Mocello, AR; Musick, B; Patel, RC; Shepherd, BE; Stalter, RM; Wools-Kaloustian, K; Yiannoutsos, CT | 1 |
| Brache, V; Chandra, N; Clark, MR; Cochon, L; Doncel, GF; Erikson, DW; Fichorova, RN; Hanif, H; Herold, BC; Jacot, T; Ju, S; Marzinke, MA; Ouattara, LA; Parikh, U; Peet, M; Schwartz, JL; Thurman, AR; Tolley, E; Yousefieh, N | 1 |
| Chen, PL; Deese, J; Gao, X; Heffron, R; Hobbs, M; Jaspan, H; Lapple, D; Miller, A; Nair, G; Onono, M; Palanee-Phillips, T; Reddy, K; Steiner, MJ | 1 |
| Badal-Faesen, S; Barr, E; Belaunzaran-Zamudio, PF; Cohn, SE; Gadama, L; Gatechompol, S; Godfrey, C; Jalil, EM; Mawlana, S; Mngqibisa, R; Olefsky, M; Pham, M; Podany, AT; Scarsi, KK; Smeaton, LM; Supparatpinyo, K; Woolley, E | 1 |
| Cohen, J; Reed, S; Shull, D | 1 |
| Byakika-Kibwika, P; Chappell, CA; Cirrincione, LR; Cohn, SE; Fletcher, CV; Kyohairwe, I; Lamorde, M; Mackline, H; Nakalema, S; Owen, A; Pham, MM; Scarsi, KK; Siccardi, M; Winchester, L | 1 |
| Agyemang, N; Badal-Faesen, S; Baker, P; Barr, E; Belaunzaran-Zamudio, PF; Cohn, SE; Gadama, L; Gatechompol, S; Godfrey, C; Haas, DW; Jalil, EM; Kayama, C; Mawlana, S; Mngqibisa, R; Olefsky, M; Pham, M; Podany, AT; Scarsi, KK; Smeaton, LM; Supparatpinyo, K; Van Schalkwyk, M; Woolley, E | 1 |
| Cohen, CE; Garvey, L; Heskin, J; Leung, S; Naous, N; Oddie, PD | 1 |
| Chinula, L; Corbett, AH; Cottrell, ML; Gajer, P; Haddad, LB; Hurst, S; Kourtis, AP; Lantz, AM; Nelson, JAE; Nicol, MR; Ravel, J; Tang, JH; Tegha, G | 1 |
| Back, S; Horgan, C; Marcus, JL; Murray Horwitz, ME; Rajbhandari, R; Snowden, JM; Tilney, RC; Toh, S; Westreich, DJ | 1 |
| Allen, S; Easter, SR; Ingabire, R; Karita, E; Kaslow, N; Mukamuyango, J; Nyirazinyoye, L; Nyombayire, J; Parker, R; Tichacek, A; Wall, KM | 1 |
| Aceves, KM; Calla, NEQ; Cherpes, TL; Lopez, FCD; Miguel, RDV | 1 |
| Hapgood, JP | 1 |
| Achilles, S; Balkus, JE; Marrazzo, J; Noguchi, L | 1 |
| Gollub, EL; Jones, H; Padian, N; Ralph, L; Stein, Z; van de Wijgert, JHHM | 1 |
| Gollub, EL; Hallett, TB; Jewell, BL; Jones, HE; Padian, NS; Ralph, LJ; Smith, JA; van de Wijgert, JHHM | 1 |
| Chen, PL; Hoover, DR; Jones, HE; Langwenya, N; Myer, L; Petro, G; Todd, CS | 1 |
| Avenant, C; Dlamini, S; Enfield, K; Hapgood, JP; Kuipa, M | 1 |
| Devezin, T; Dube, GS; Kay, AW; Lukhele, B; Mandalakas, AM; Mkhabela, M; Mtetwa, G; Ndlovu, B; Sandoval, M; Sibanda, J; Sikhondze, W; Stevens, RH; Vambe, D | 1 |
| Chinula, L; Ellington, S; Haddad, LB; Hosseinipour, MC; Hurst, S; Kourtis, AP; Mataya, R; Msika, A; Nelson, JAE; Tang, JH; Tegha, G; Wiener, J | 1 |
| Asin, SN; Brache, V; Chandra, N; Clark, MR; Dezzutti, CS; Doncel, GF; Fichorova, R; Herold, BC; Hillier, SL; Kiser, P; Marzinke, MA; McCormick, T; Rollenhagen, C; Schwartz, JL; Stanczyk, FZ; Thurman, AR; Weiner, D | 1 |
| Bosinger, SE; Butler, K; Dietz Ostergaard, S; Ellis, S; Johnson, RL; Kersh, EN; McNicholl, JM; Patel, NB; Payne, TL; Tharp, GK; Vishwanathan, SA; Zhao, C | 1 |
| Baiamonte, L; Drobnis, EZ; Hope, TJ; Huang, L; Li, L; Mills, M; Quayle, AJ; Schust, DJ; Stark, M; Tu, J; Wang, W; Zhou, J | 1 |
| Chinula, L; Corbett, A; Cottrell, ML; Haddad, LB; Hurst, S; Kourtis, AP; Msika, A; Nelson, JAE; Tang, JH; Wiener, J | 1 |
| Akers, J; Augustine, MS; Buckner, LR; Drobnis, EZ; Hope, TJ; Mott, PD; Quayle, AJ; Rogers, LK; Schust, DJ | 1 |
| Anderson, SM; Doncel, GF; Gajer, P; Marzinke, MA; Ravel, J; Schwartz, JL; Thurman, AR; Yousefieh, N | 1 |
| Noguchi, LM; Simelela, PN | 1 |
| Baeten, JM; Blue, SW; Erikson, DW; Kelly, EJ; Kim, CJ; Kourtis, AP; Lingappa, JR; Mugo, N; Nanda, K; Patel, RC; Scarsi, KK; Stalter, RM; Tamraz, B; Thomas, KK | 1 |
| Agnew, K; Balkus, J; Cohen, CR; Coleman, JS; Coombs, RW; Hitti, J; Muliro, A; Mwachari, C; Sanguli, L | 1 |
| Chen, PL; Hubacher, D; Kiarie, J; Liku, J; Muiruri, P; Omwenga, J; Rakwar, J | 1 |
| Gray, R; Kigozi, G; Kong, X; Lutalo, T; Makumbi, F; Musoke, R; Nalugoda, F; Sekasanvu, J; Serwadda, D; Sewankambo, N; Wawer, M | 1 |
| Matthews, CM; Prescott, GM | 1 |
| Andreasen, AK; Clark, JT; Clark, MR; Fabian, J; Friend, DR; Johnson, TJ; Kiser, PF; Nebeker, JS; Shelke, NB; Smith, EM | 1 |
| Rey-Salmon, C | 1 |
| Deese, J; Hubacher, D; Otunga, S; Steiner, MJ; Todd, CS; Van Damme, L; Wang, M | 1 |
| Butler, K; Dietz Ostergaard, S; Johnson, R; Kersh, EN; Lathrop, G; McNicholl, JM; Powell, N; Ritter, JM; Sanders, J; Zaki, SR | 1 |
| Coriat, R; Loulergue, P; Mir, O | 1 |
| Chappell, CA; Dezzutti, CS; Hillier, SL; Isaacs, CE; Meyn, LA; Moncla, BJ; Uranker, K; Xu, W | 1 |
| Aravantinou, M; Blanchard, J; Derby, N; Fernández-Romero, JA; Gettie, A; Grasperge, B; Kenney, J; Kizima, L; Kumar, N; Levendosky, K; Mizenina, O; Robbiani, M; Roberts, K; Rodriguez, A; Seidor, S; Ugaonkar, SR; Wesenberg, A; Wilk, J; Zhang, S; Zydowsky, TM | 1 |
| Byamugisha, JK; Gemzell-Danielsson, K; Kakaire, O; Tumwesigye, NM | 1 |
| Back, DJ; Buzibye, A; Byakika-Kibwika, P; Cohn, SE; Darin, KM; Dilly Penchala, S; Else, LJ; Lamorde, M; Merry, C; Nakalema, S; Scarsi, KK | 1 |
| Brimer, A; Devlin, B; Major, I; McConville, C | 1 |
| Averbach, S; Critchfield, JW; Giudice, LC; Greenblatt, RM; Hilton, JF; Seidman, D; Shacklett, BL; Shanmugasundaram, U; Smith-McCune, K | 1 |
| Achilles, SL; Hillier, SL; Phillips, SJ; Polis, CB | 1 |
| Cherpes, TL; Quispe Calla, NE; Trout, W; Vicetti Miguel, RD | 1 |
| Chinula, L; Corbett, A; De Paris, K; Ellington, S; Haddad, L; Hoffman, IF; Hosseinipour, M; Hurst, S; Jamieson, DJ; King, CC; Kourtis, AP; Nelson, JA; Tang, J; Wiener, J | 1 |
| Back, DJ; Byakika-Kibwika, P; Darin, KM; Lamorde, M; Merry, C; Neary, M; Olagunju, A; Owen, A; Scarsi, KK; Siccardi, M | 1 |
| Bahamondes, L; Bahamondes, MV; Monteiro, I | 1 |
| Adams, B; Alonzo, TA; Cremer, M; Holland, E; Klausner, D; Nichols, S; Scott Ram, R | 1 |
| Aho, I; Heikinheimo, O; Lehtovirta, P; Paavonen, J; Ristola, M | 1 |
| Okonofua, FE | 1 |
| Heikinheimo, O; Lehtovirta, P; Paavonen, J; Suni, J | 1 |
| Heikinheimo, O; Lehtovirta, P; Paavonen, J | 1 |
| Baeten, JM; Hassan, WM; Jaoko, W; Kiarie, J; Lavreys, L; Mandaliya, K; McClelland, RS; Ndinya-Achola, J; Sangare, L | 1 |
| Abel, S; Muirhead, GJ; Ridgway, CE; Russell, D; Whitlock, LA | 1 |
| Bateman, L; Frank, ML; Poindexter, AN | 1 |
| Cohen, J | 1 |
3 review(s) available for levonorgestrel and HIV Coinfection
| Article | Year |
|---|---|
Drug-induced liver injury secondary to increased levonorgestrel exposure in a patient taking ritonavir.
Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Darunavir; Female; HIV Infections; Humans; Levonorgestrel; Ritonavir; Tenofovir | 2023 |
Long-acting reversible contraception: a review in special populations.
Topics: Age Factors; Animals; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Risk Factors; Sexually Transmitted Diseases | 2014 |
Levonorgestrel-releasing intrauterine system: uses and controversies.
Topics: Contraception; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometriosis; Endometrium; Estrogen Replacement Therapy; Female; Genital Diseases, Female; HIV Infections; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Risk Assessment; Thrombophilia; Treatment Outcome; Uterine Neoplasms | 2008 |
24 trial(s) available for levonorgestrel and HIV Coinfection
| Article | Year |
|---|---|
Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial.
Topics: Contraception; Contraceptive Agents, Female; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Progestins | 2021 |
Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.
Topics: Contraception; Contraceptive Agents, Female; Female; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Male; Medroxyprogesterone Acetate | 2022 |
A phase 1, open-label study to evaluate the drug interaction between islatravir (MK-8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.
Topics: Adult; Contraception; Contraceptives, Oral, Combined; Deoxyadenosines; Drug Interactions; Ethinyl Estradiol; Female; HIV Infections; Humans; Levonorgestrel | 2021 |
The Effect of Contraception on Genital Cytokines in Women Randomized to Copper Intrauterine Device, Depot Medroxyprogesterone Acetate, or Levonorgestrel Implant.
Topics: Contraception; Contraceptive Agents, Female; Cytokines; Female; Genitalia; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate | 2022 |
Genital inflammatory status and the innate immune response to contraceptive initiation.
Topics: Contraceptive Agents, Female; Cytokines; Female; Genitalia; HIV Infections; Humans; Immunity, Innate; Inflammation; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate | 2022 |
Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya.
Topics: Administration, Intravaginal; Female; HIV Infections; Humans; Kenya; Levonorgestrel; Microbiota; RNA, Ribosomal, 16S; Tenofovir; Vagina | 2022 |
Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.
Topics: Contraceptive Agents, Female; Copper; Disease Susceptibility; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Proteomics; South Africa; Vagina | 2022 |
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.
Topics: Anovulation; Antiviral Agents; Contraceptive Agents; Contraceptive Devices, Female; Diphosphates; Female; HIV Core Protein p24; HIV Infections; Humans; Levonorgestrel; Male; Semen; Tenofovir | 2022 |
Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial.
Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Male; Medroxyprogesterone Acetate; Prostate-Specific Antigen; Random Allocation; South Africa; Unsafe Sex | 2023 |
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens.
Topics: Adolescent; Benzoxazines; Contraception, Postcoital; Female; HIV Infections; Humans; Levonorgestrel; Rifampin; Tuberculosis | 2023 |
Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
Topics: Adolescent; Adult; Benzoxazines; Contraceptive Agents, Female; Female; HIV Infections; Humans; Levonorgestrel; Middle Aged; Pregnancy; Young Adult | 2023 |
Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Male; South Africa; Treatment Outcome; Young Adult | 2020 |
Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
Topics: Adult; Anti-Retroviral Agents; Contraceptive Agents, Female; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Vaginal Smears; Virus Shedding | 2018 |
Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.
Topics: Adult; Contraceptive Devices, Female; Female; HIV Infections; HIV-1; Humans; Levonorgestrel; Models, Biological; Tenofovir | 2018 |
Brief Report: HIV Shedding in the Female Genital Tract of Women on ART and Progestin Contraception: Extended Follow-up Results of a Randomized Clinical Trial.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cervix Uteri; Contraception; Contraceptive Agents, Female; Cyclopropanes; Drug Implants; Female; Follow-Up Studies; Genitalia, Female; HIV Infections; Humans; Levonorgestrel; Malawi; Medroxyprogesterone Acetate; Progestins; Treatment Outcome; Virus Shedding | 2019 |
Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
Topics: Adenine; Adult; Anti-HIV Agents; Antiviral Agents; Contraceptive Agents, Hormonal; Contraceptive Devices, Female; Device Removal; Female; Herpes Genitalis; HIV Infections; Humans; Levonorgestrel; Microbiota; Middle Aged; Mucous Membrane; Organophosphates; Tenofovir; Vagina; Young Adult | 2019 |
HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Topics: Adolescent; Adult; Eswatini; Family Planning Services; Female; HIV Infections; Humans; Incidence; Intention to Treat Analysis; Intrauterine Devices, Copper; Kenya; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; South Africa; Young Adult; Zambia | 2019 |
Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya.
Topics: Adenine; Adolescent; Adult; Antiviral Agents; Contraceptive Agents, Female; Deoxycytidine; Drug Combinations; Drug Implants; Emtricitabine; Female; HIV Infections; Humans; Kenya; Levonorgestrel; Longitudinal Studies; Organophosphonates; Polypharmacy; Prospective Studies; Tenofovir; Young Adult | 2015 |
Intrauterine Contraception Among Women Living With Human Immunodeficiency Virus: A Randomized Controlled Trial.
Topics: Adult; Contraceptive Agents, Female; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Patient Compliance; Pregnancy; Young Adult | 2015 |
Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Levonorgestrel; Nevirapine; Pregnancy; Pregnancy, Unplanned; Reverse Transcriptase Inhibitors; Time Factors; Uganda | 2016 |
Effects of the levonorgestrel-releasing intrauterine device on the immune microenvironment of the human cervix and endometrium.
Topics: Adult; Cervix Uteri; Cross-Sectional Studies; Drug Delivery Systems; Endometrium; Female; HIV Infections; HLA-DR Antigens; Humans; Interleukin-10; Levonorgestrel; Middle Aged; Receptors, CCR4; Receptors, CCR5; Risk Factors; T-Lymphocytes | 2016 |
A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.
Topics: Anti-HIV Agents; Case-Control Studies; Cervix Uteri; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; HIV Infections; Humans; Levonorgestrel; Malawi; Medroxyprogesterone Acetate; Mucous Membrane; Pilot Projects; Research; Treatment Outcome; Vagina; Virus Shedding | 2017 |
The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine.
Topics: Adult; Alkynes; Area Under Curve; Benzoxazines; Constitutive Androstane Receptor; Contraceptive Agents, Female; Cyclopropanes; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Female; Genetic Variation; HIV Infections; Humans; Levonorgestrel; Linear Models; Multivariate Analysis; Nevirapine; Pharmacogenetics; Polymorphism, Single Nucleotide; Prospective Studies; Reverse Transcriptase Inhibitors | 2017 |
Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/zidovudine, and ethinyloestradiol/levonorgestrel in healthy volunteers.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anti-HIV Agents; CCR5 Receptor Antagonists; Contraceptives, Oral; Cyclohexanes; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; HIV Infections; Humans; Lamivudine; Levonorgestrel; Male; Maraviroc; Midazolam; Middle Aged; Statistics as Topic; Triazoles; Zidovudine | 2008 |
40 other study(ies) available for levonorgestrel and HIV Coinfection
| Article | Year |
|---|---|
Long-acting biodegradable implant for sustained delivery of antiretrovirals (ARVs) and hormones.
Topics: Absorbable Implants; Anti-Retroviral Agents; Female; HIV Infections; Hormones; Humans; Levonorgestrel; Pregnancy | 2021 |
Pharmacokinetics of levonorgestrel and etonogestrel contraceptive implants over 48 weeks with rilpivirine- or darunavir-based antiretroviral therapy.
Topics: Contraceptive Agents; Darunavir; Female; HIV Infections; Humans; Levonorgestrel; Progestins; Rilpivirine; Ritonavir | 2022 |
Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis.
Topics: Adolescent; Adult; Alkynes; Benzoxazines; Contraceptive Agents; Cyclopropanes; Female; HIV Infections; Humans; Levonorgestrel; Middle Aged; Nevirapine; Pregnancy; Retrospective Studies; Young Adult | 2022 |
Co-delivery of an HIV prophylactic and contraceptive using PGSU as a long-acting multipurpose prevention technology.
Topics: Contraceptive Agents, Female; Diazonium Compounds; Female; HIV Infections; Humans; Levonorgestrel; Pregnancy | 2023 |
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis.
Topics: Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Contraception, Postcoital; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Female; Genotype; HIV Infections; Humans; Isoniazid; Levonorgestrel; Pharmacogenetics; Rifampin; Tuberculosis | 2023 |
Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in Malawi.
Topics: Anti-Retroviral Agents; Female; HIV Infections; Hormonal Contraception; Humans; Lamivudine; Levonorgestrel; Malawi; Medroxyprogesterone Acetate; Microbiota; Tenofovir; Vagina | 2023 |
Use of Intrauterine Devices and Risk of Human Immunodeficiency Virus Acquisition Among Insured Women in the United States.
Topics: Female; HIV; HIV Infections; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; United States | 2020 |
Motivational interviewing to promote long-acting reversible contraception among Rwandan couples wishing to prevent or delay pregnancy.
Topics: Adult; Catholicism; Contraceptive Agents, Female; Drug Implants; Family Planning Services; Female; HIV Infections; Humans; Income; Intrauterine Devices, Copper; Islam; Levonorgestrel; Long-Acting Reversible Contraception; Male; Motivational Interviewing; Protestantism; Rwanda; Spouses | 2020 |
ECHO: context and limitations.
Topics: Contraception; Female; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate | 2020 |
ECHO: context and limitations.
Topics: Contraception; Female; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate | 2020 |
ECHO: context and limitations.
Topics: Contraception; Female; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate | 2020 |
ECHO: context and limitations.
Topics: Contraception; Female; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate | 2020 |
ECHO: context and limitations.
Topics: Contraception; Female; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate | 2020 |
Maraviroc, tenofovir disoproxil fumarate and dapivirine, activate progesterone receptor B in the absence of progestogens.
Topics: Anti-HIV Agents; Binding, Competitive; Cell Line; Contraceptive Agents, Hormonal; HIV Infections; HIV-1; Humans; Immunologic Factors; In Vitro Techniques; Levonorgestrel; Maraviroc; Phosphorylation; Progesterone Congeners; Pyrimidines; Receptors, Progesterone; Tenofovir; Transcriptional Activation | 2020 |
Vikela Ekhaya: A Novel, Community-based, Tuberculosis Contact Management Program in a High Burden Setting.
Topics: Adult; Child; Contact Tracing; HIV Infections; Humans; Isoniazid; Levonorgestrel; Rifampin; Tuberculosis | 2022 |
Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
Topics: Animals; Contraception; Contraceptive Agents, Female; Ethinyl Estradiol; Female; HIV Infections; Interleukin-10; Levonorgestrel; Macaca nemestrina; Medroxyprogesterone Acetate; Mucous Membrane; Progestins; Risk Factors; Vagina | 2018 |
Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood.
Topics: Adult; Cervix Uteri; Contraception; Contraceptive Agents, Female; Desogestrel; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Receptors, CCR5; Receptors, CXCR4; T-Lymphocytes; Young Adult | 2019 |
Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission.
Topics: Adolescent; Adult; Cervix Uteri; Contraception; Contraceptive Agents, Female; Desogestrel; Female; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Young Adult | 2019 |
How should we listen to ECHO?
Topics: Clinical Decision-Making; Clinical Trials as Topic; Contraception; Copper; Female; HIV Infections; Humans; Intention to Treat Analysis; Intrauterine Devices; Kenya; Levonorgestrel; Observational Studies as Topic; Practice Guidelines as Topic; South Africa; Zambia | 2019 |
A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Desogestrel; Drug Antagonism; Female; HIV Infections; Humans; Kenya; Levonorgestrel; Linear Models; Nevirapine; Pharmacogenomic Testing; Uganda | 2019 |
Effect of the levonorgestrel intrauterine device on genital HIV-1 RNA shedding among HIV-1-infected women not taking antiretroviral therapy in Nairobi, Kenya.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cervix Uteri; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Interleukin-1beta; Intrauterine Devices, Medicated; Kenya; Levonorgestrel; RNA, Viral; Vaginal Douching | 2013 |
Effect of concurrent use of anti-retroviral therapy and levonorgestrel sub-dermal implant for contraception on CD4 counts: a prospective cohort study in Kenya.
Topics: Adolescent; Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Contraceptive Agents; Female; HIV Infections; Humans; Kenya; Levonorgestrel; Pregnancy; Prospective Studies; Young Adult | 2013 |
Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples.
Topics: Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral; Family Characteristics; Female; HIV Infections; Humans; Incidence; Levonorgestrel; Male; Medroxyprogesterone Acetate; Middle Aged; Retrospective Studies; Risk Assessment; Uganda; Young Adult | 2013 |
Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy.
Topics: Algorithms; Animals; Contraceptive Agents, Female; Contraceptive Devices, Female; Drug Delivery Systems; Elasticity; Female; HIV Infections; Humans; Levonorgestrel; Models, Theoretical; Polyurethanes; Pregnancy; Pregnancy, Unwanted; Rabbits; Tensile Strength | 2014 |
[Medical evaluation of suspected child and adolescent sexual abuse].
Topics: Adolescent; Anti-HIV Agents; Child; Child Abuse, Sexual; Child Behavior Disorders; Drug Therapy, Combination; Emergencies; Gynecological Examination; Hepatitis B; HIV Infections; Hospitalization; Humans; Levonorgestrel; Physical Examination; Sex Offenses; Wounds and Injuries | 2014 |
A combined oral contraceptive affects mucosal SHIV susceptibility factors in a pigtail macaque (Macaca nemestrina) model.
Topics: Animals; Contraceptives, Oral, Combined; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; HIV Infections; Levonorgestrel; Macaca nemestrina; Menstrual Cycle; Mucous Membrane; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Vagina | 2015 |
Recurrent transaminitis induced by oral contraceptives during HIV infection.
Topics: Alanine Transaminase; Anti-HIV Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Contraceptives, Oral; Ethinyl Estradiol; Female; HIV Infections; Humans; Levonorgestrel; Middle Aged | 2015 |
The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
Topics: Adult; Cervix Uteri; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Immunity, Innate; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Postmenopause; Premenopause; Vagina; Vaginal Douching; Viral Plaque Assay; Young Adult | 2015 |
A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
Topics: Administration, Intravaginal; Animals; Antiviral Agents; Carrageenan; Cell Line; Contraceptive Agents, Female; Contraceptive Devices, Female; Drug Delivery Systems; Equipment Design; Female; HeLa Cells; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Reverse Transcriptase; HIV-1; Human papillomavirus 16; Humans; Levonorgestrel; Macaca mulatta; Papillomavirus Infections; Pregnancy; Pyridines; Urea; Zinc Acetate | 2015 |
Development of a multi-layered vaginal tablet containing dapivirine, levonorgestrel and acyclovir for use as a multipurpose prevention technology.
Topics: Acyclovir; Contraceptive Devices, Female; Female; HIV Infections; Humans; Levonorgestrel; Pyrimidines; Tablets; Vagina | 2016 |
Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?
Topics: Contraceptive Agents, Female; HIV Infections; Humans; Levonorgestrel; Progestins | 2016 |
HIV and Hormonal Contraception: Bench and Bedside.
Topics: Adolescent; Adult; Cervix Uteri; Female; HIV Infections; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Permeability; Young Adult | 2017 |
Adolescent comprehension of emergency contraception in New York City.
Topics: Adolescent; Child; Contraception Behavior; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Levonorgestrel; New York City; Psychology, Adolescent; Surveys and Questionnaires | 2009 |
The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study.
Topics: Analysis of Variance; Contraceptive Agents, Female; Female; Follow-Up Studies; HIV Infections; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lymphocyte Count; Statistics, Nonparametric; Women | 2011 |
Rethinking contraception in Africa in the era of HIV/AIDS.
Topics: Africa; Condoms; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Family Planning Services; Health Promotion; HIV Infections; Humans; Levonorgestrel; Needs Assessment; Pregnancy, Unplanned; Risk Factors; Spermatocidal Agents | 2004 |
The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.
Topics: Contraceptive Agents, Female; Estradiol; Female; HIV; HIV Infections; Humans; Levonorgestrel; Menstruation; Ovary; Prospective Studies; Uterus; Viral Load; Virus Shedding | 2006 |
Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
Topics: Adult; Contraceptive Agents, Female; Female; HIV Infections; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menorrhagia; Menstruation; Middle Aged; Pelvic Inflammatory Disease; Safety; Treatment Outcome; Virus Shedding | 2007 |
Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.
Topics: Adult; Alcohol Drinking; Delayed-Action Preparations; Education; Female; HIV Infections; HIV-1; Humans; Kenya; Levonorgestrel; Medroxyprogesterone Acetate; Risk Factors; Sex Work; Time Factors; Trichomonas Vaginitis | 2007 |
Planned condom use by women with Norplant implants.
Topics: Adolescent; Adult; Age Factors; Black or African American; Condoms; Drug Implants; Female; Hispanic or Latino; HIV Infections; Humans; Income; Levonorgestrel; Marital Status; Sexually Transmitted Diseases; White People | 1993 |
SIV transmission. Monkey study prompts high-level public health response.
Topics: Animals; Contraceptive Agents, Female; Disease Models, Animal; Epithelium; Female; Haplorhini; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progesterone; Risk Factors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Vagina | 1996 |